TTD | Drug: D0L1CX

Drug General Information
Drug ID	D0L1CX
Former ID	DNC009922
Drug Name	N-{4-[2-(3-Hydroxyphenyl)ethyl]phenyl}phthalimide
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[530220]
Structure		Download 2D MOL 3D MOL
Formula	C22H17NO3
Canonical SMILES	C1=CC=C2C(=C1)C(=O)N(C2=O)C3=CC=C(C=C3)CCC4=CC(=CC=C4)O
InChI	1S/C22H17NO3/c24-18-5-3-4-16(14-18)9-8-15-10-12-17(13-11-15)23-21(25)19-6-1-2-7-20(19)22(23)26/h1-7,10-14,24H,8-9H2
InChIKey	TUMZBTITCWKZAT-UHFFFAOYSA-N
PubChem Compound ID	45481863
Target and Pathway
Target(s)	Oxysterols receptor LXR-alpha	Target Info	Inhibitor	[530220]
KEGG Pathway	PPAR signaling pathway
	Non-alcoholic fatty liver disease (NAFLD)
	Hepatitis C
Pathway Interaction Database	RXR and RAR heterodimerization with other nuclear receptor
WikiPathways	Nuclear Receptors in Lipid Metabolism and Toxicity
	Nuclear Receptors Meta-Pathway
	PPAR Alpha Pathway
	Liver X Receptor Pathway
	Adipogenesis
	SREBF and miR33 in cholesterol and lipid homeostasis
	Nuclear Receptors
References
Ref 530220	Bioorg Med Chem. 2009 Jul 15;17(14):5001-14. Epub 2009 Jun 2.Separation of alpha-glucosidase-inhibitory and liver X receptor-antagonistic activities of phenethylphenyl phthalimide analogs and generation of LXRalpha-selective antagonists.
Ref 530220	Bioorg Med Chem. 2009 Jul 15;17(14):5001-14. Epub 2009 Jun 2.Separation of alpha-glucosidase-inhibitory and liver X receptor-antagonistic activities of phenethylphenyl phthalimide analogs and generation of LXRalpha-selective antagonists.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.

Drug Information